1 April 2024 false Taxfiler 2024.6 11760986business:PrivateLimitedCompanyLtd2024-04-012025-03-31 117609862024-03-31 117609862024-04-012025-03-31 11760986business:AuditExemptWithAccountantsReport2024-04-012025-03-31 11760986business:FilletedAccounts2024-04-012025-03-31 117609862025-03-31 11760986business:Director12024-04-012025-03-31 11760986business:Director22024-04-012025-03-31 11760986business:RegisteredOffice2024-04-012025-03-31 117609862024-03-31 11760986core:WithinOneYear2025-03-31 11760986core:WithinOneYear2024-03-31 11760986core:AfterOneYear2025-03-31 11760986core:AfterOneYear2024-03-31 11760986core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 11760986core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 11760986core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 11760986core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 11760986core:PreviouslyStatedAmount2025-03-31 11760986core:PreviouslyStatedAmount2024-03-31 11760986business:SmallEntities2024-04-012025-03-31 11760986countries:EnglandWales2024-04-012025-03-31 117609862023-04-012024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 11760986 (England and Wales)
A&M Pharmacy Ltd Unaudited accounts for the year ended 31 March 2025
A&M Pharmacy Ltd Unaudited accounts Contents
Page
- 2 -
A&M Pharmacy Ltd Company Information for the year ended 31 March 2025
Directors
A Akram H Malik
Company Number
11760986 (England and Wales)
Registered Office
Ferndene West Park Road Gateshead Tyne and Wear NE8 4SP England
Accountants
Ask Accountants NE Limited The Grainger Suite, Dobson House Regent Centre Newcastle Upon Tyne Tyne And Wear NE3 3PF
- 3 -
A&M Pharmacy Ltd Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Investments
1,011,089 
1,011,089 
Current assets
Debtors
179,385 
- 
Cash at bank and in hand
7,588 
6,359 
186,973 
6,359 
Creditors: amounts falling due within one year
(656,728)
(406,759)
Net current liabilities
(469,755)
(400,400)
Total assets less current liabilities
541,334 
610,689 
Creditors: amounts falling due after more than one year
(430,595)
(470,294)
Net assets
110,739 
140,395 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
110,639 
140,295 
Shareholders' funds
110,739 
140,395 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 22 December 2025 and were signed on its behalf by
A Akram Director Company Registration No. 11760986
- 4 -
A&M Pharmacy Ltd Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
A&M Pharmacy Ltd is a private company, limited by shares, registered in England and Wales, registration number 11760986. The registered office is Ferndene, West Park Road, Gateshead, Tyne and Wear, NE8 4SP, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention.
Presentation currency
The accounts have been prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
Investments
Investments in subsidiaries are initially measured at cost and subsequently measured a cost less any accumulated impairment. The investments are assessed for impairment at each reporting date.
4
Investments
Subsidiary undertakings 
£ 
Valuation at 1 April 2024
1,011,089 
Valuation at 31 March 2025
1,011,089 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due after more than one year
Other debtors
179,385 
- 
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Bank loans and overdrafts
40,006 
35,684 
Taxes and social security
16,221 
16,221 
Other creditors
600,501 
354,854 
656,728 
406,759 
- 5 -
A&M Pharmacy Ltd Notes to the Accounts for the year ended 31 March 2025
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Bank loans
430,595 
470,294 
8
Average number of employees
During the year the average number of employees was 2 (2024: 2).
- 6 -